|Articles|November 1, 2017
- Pharmaceutical Executive-11-01-2017
- Volume 37
- Issue 11
Pharmaceutical Executive, November 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's 2018 Pipeline Reportover 8 years ago
Taiwan’s Biotech Boomover 8 years ago
The Fine Line of Pharma & Patient Group Collaborationover 8 years ago
FDA Explores Flexible Drug Marketing Policiesover 8 years ago
No Overnight Successesover 8 years ago
Aligning Early Advice with Long-Term Planningover 8 years ago
Navigating the Untapped NASH Marketover 8 years ago
Interpreting UK’s Post-Brexit Life Sciences Strategyover 8 years ago
When HIPAA Doesn’t Applyover 8 years ago
Country Report: AustriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5